Scarica l'app Stockscreener
88.00
0.76%
-0.67
Dopo l'orario di chiusura:
88.06
0.06
+0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$88.67
Aprire:
$90.02
Volume 24 ore:
3.87M
Relative Volume:
1.50
Capitalizzazione di mercato:
$10.64B
Reddito:
$6.76B
Utile/perdita netta:
$770.00M
Rapporto P/E:
14.29
EPS:
6.1566
Flusso di cassa netto:
$380.00M
1 W Prestazione:
+1.85%
1M Prestazione:
+8.63%
6M Prestazione:
-8.75%
1 anno Prestazione:
-21.75%
Intervallo 1D:
$87.44
$90.78
Intervallo di 1 settimana:
$85.25
$90.78
Portata 52W:
$79.12
$128.90
Clorox Co Stock (CLX) Company Profile
Nome
Clorox Co
Settore
Industria
Telefono
(510) 271-7000
Indirizzo
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, EL, KVUE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
88.00 | 10.64B | 6.76B | 770.00M | 380.00M | 6.1566 |
PG
Procter Gamble Co
|
161.57 | 374.48B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
65.26 | 140.54B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
95.29 | 75.96B | 20.80B | 2.22B | 3.77B | 2.5772 |
EL
Estee Lauder Cos Inc
|
109.23 | 39.58B | 14.85B | -248.00M | 1.29B | -0.6966 |
KVUE
Kenvue Inc
|
19.31 | 37.09B | 15.29B | 1.62B | 1.82B | 0.8433 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-28 | Downgrade | Jefferies | Buy → Hold |
| 2026-04-17 | Downgrade | JP Morgan | Neutral → Underweight |
| 2026-02-11 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-10-01 | Reiterato | Barclays | Underweight |
| 2025-01-07 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-11-06 | Aggiornamento | TD Cowen | Sell → Hold |
| 2024-10-01 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-23 | Iniziato | TD Cowen | Sell |
| 2024-06-24 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-04-02 | Downgrade | Citigroup | Buy → Neutral |
| 2024-03-26 | Aggiornamento | Jefferies | Underperform → Hold |
| 2024-03-01 | Ripresa | Goldman | Sell |
| 2024-02-05 | Downgrade | DA Davidson | Buy → Neutral |
| 2023-12-15 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-11-22 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-11-13 | Iniziato | Jefferies | Underperform |
| 2023-11-06 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-10-12 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-10-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-10-02 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-09-22 | Iniziato | HSBC Securities | Hold |
| 2023-08-03 | Aggiornamento | Atlantic Equities | Underweight → Neutral |
| 2023-02-17 | Iniziato | Citigroup | Neutral |
| 2022-10-18 | Iniziato | Evercore ISI | Underperform |
| 2022-10-17 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Ripresa | BofA Securities | Underperform |
| 2022-07-13 | Iniziato | Raymond James | Outperform |
| 2022-02-04 | Downgrade | Atlantic Equities | Neutral → Underweight |
| 2022-02-04 | Reiterato | Deutsche Bank | Hold |
| 2022-02-04 | Reiterato | JP Morgan | Underweight |
| 2022-02-04 | Reiterato | Morgan Stanley | Underweight |
| 2022-02-04 | Reiterato | UBS | Sell |
| 2022-02-04 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | Bernstein | Mkt Perform → Underperform |
| 2022-01-26 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-11-02 | Reiterato | DA Davidson | Neutral |
| 2021-11-02 | Reiterato | Deutsche Bank | Hold |
| 2021-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-11-02 | Reiterato | Wells Fargo | Underweight |
| 2021-09-03 | Downgrade | Argus | Buy → Hold |
| 2021-08-04 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-08-04 | Reiterato | Citigroup | Buy |
| 2021-08-04 | Reiterato | Credit Suisse | Neutral |
| 2021-08-04 | Reiterato | Deutsche Bank | Hold |
| 2021-08-04 | Reiterato | Morgan Stanley | Underweight |
| 2021-08-04 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2021-08-04 | Reiterato | UBS | Sell |
| 2021-08-04 | Reiterato | Wells Fargo | Underweight |
| 2021-06-24 | Iniziato | UBS | Sell |
| 2021-05-03 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2021-03-18 | Downgrade | DA Davidson | Buy → Neutral |
| 2021-02-19 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-01-20 | Iniziato | Bernstein | Mkt Perform |
| 2020-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-12-08 | Iniziato | Wells Fargo | Overweight |
| 2020-10-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-30 | Iniziato | DA Davidson | Buy |
| 2020-03-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2020-03-16 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2020-03-09 | Aggiornamento | Argus | Hold → Buy |
| 2019-10-03 | Reiterato | BofA/Merrill | Neutral |
| 2019-09-23 | Downgrade | Barclays | Equal Weight → Underweight |
| 2019-05-20 | Downgrade | Argus | Buy → Hold |
| 2019-05-02 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-02 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2019-04-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-03-07 | Iniziato | Credit Suisse | Outperform |
| 2018-12-06 | Reiterato | BofA/Merrill | Neutral |
| 2018-09-25 | Aggiornamento | Argus | Hold → Buy |
| 2018-07-18 | Downgrade | Goldman | Neutral → Sell |
| 2018-04-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-02-08 | Downgrade | Argus | Buy → Hold |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
Mostra tutto
Clorox Co Borsa (CLX) Ultime notizie
Fabian Garcia Appointed Chief Executive Officer of The Clorox Company - https://hrtoday.in/
Clorox's Q1 Earnings Coming Up: Key Insights for Investors - Zacks Investment Research
Clorox's Q1 Earnings Coming Up: Key Insights for Investors - TradingView
Colgate-Palmolive (CL) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research
Clorox names Fabian Garcia as CEO - World Aerosols
Clorox Company (The) (CLX) Stock Forecasts - Yahoo Finance
The Clorox Company (CLX) Seasonal Returns ChartYahoo Finance - Yahoo! Finance Canada
The Clorox Company (CLX) Seasonal returns chart - Yahoo Finance Australia
Clorox appoints Unilever executive as its new CEO - Reuters
Clorox finds next CEO, a Unilever executive who sits on Wells Fargo's board - The Business Journals
Clorox (CLX) Taps Fabian Garcia As Its Next CEO - Yahoo Finance
Incoming Clorox CEO Fabian Garcia to Step in Amid ERP, Portfolio Optimization - Consumer Goods Technology
The Clorox Company Appoints Fabian Garcia as CEO, Effective January 5, 2027 - marketscreener.com
Clorox: An Easy Quarter Ahead, But A Harder Test For The Dividend - Seeking Alpha
Clorox Appoints Unilever Executive Fabian Garcia as CEO, Succeeding Linda Rendle - citybiz
Clorox Appoints Fabian Garcia as CEO - The Clorox Company
The Clorox Company Appoints Fabian Garcia CEO Effective Jan. 5, 2027 - TradingView
Clorox uses AI to adjust ads while campaigns run - ContentGrip
How Clorox uses AI and consumer feedback to improve marketing campaigns - Marketing Tech News
Is Clorox’s 6% Dividend Yield Safe? The Nov. 2 Earnings Report Could Decide - 24/7 Wall St.
Is Clorox’s 6% Dividend Yield Safe? The Nov. 2 Earnings Report Could Decide - Yahoo Finance
The Clorox Company $CLX Shares Sold by Prime Capital Investment Advisors LLC - MarketBeat
The Clorox Company $CLX Stock Holdings Increased by Citizens Financial Group Inc. RI - MarketBeat
The Clorox Company $CLX Shares Purchased by Blume Capital Management Inc. - MarketBeat
Macroeconomic Headwinds are Hitting Clorox From All Sides - The Motley Fool
Should You Forget Clorox Stock Near a 52-Week Low? - The Motley Fool
Should You Forget Clorox Stock Near a 52-Week Low? - Yahoo Finance
UBS Sees Clorox Growth Still Under Pressure In Fiscal Q1 - Finimize
Clorox's Fiscal Q1 Organic Sales Growth to Stay Pressured, With Costs Impacting Earnings, UBS Says - marketscreener.com
How Clorox brands build continuous relevance with consumers - The Clorox Company
Why Clorox shifted from creating brand campaigns to systems of relevance - Marketing Dive
Clorox (CLX) Earnings Expected to Grow: Should You Buy? - Zacks Investment Research
Clorox (CLX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
5 Top Dividend Stocks Yielding 5% or More to Buy Right Now for Passive Income - The Motley Fool
Clorox Co. stock underperforms Friday when compared to competitors - MarketWatch
Clorox Company (The) Estimates – NYSE:CLX - TradingView
RH (RH) Surges 9.5%: Is This an Indication of Further Gains? - Zacks Investment Research
Clorox Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Clorox Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Clorox (NYSE:CLX) In Focus As Cleaning-Brand Demand Steadies - Kalkine Media
The Clorox Company $CLX Stake Increased by Vest Financial LLC - MarketBeat
Clorox Co Lobbying Profile, 2019 - OpenSecrets
Clorox Co (CLX) Stock Down 3.1% -- Now Undervalued? GF Score: 69/100 - GuruFocus
Clorox Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend - Yahoo Finance
Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend - 24/7 Wall St.
4 Top Dividend Stocks Yielding 4% or More to Buy Right Now for Passive Income - The Motley Fool
Clorox Combines Professional, Purell Businesses in New B2B Platform - National Association of Wholesaler-Distributors
Clorox Co. stock outperforms competitors on strong trading day - MarketWatch
Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap? - 24/7 Wall St.
Clorox Co Azioni (CLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clorox Co Azioni (CLX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Breber Pierre R | Director |
Nov 21 '25 |
Buy |
104.13 |
4,000 |
416,516 |
13,000 |
1.12%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):